Article
Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination.
Current opinion in infectious diseases - 1 Oct 2021
Dhorda Mehul, Amaratunga Chanaki, Dondorp Arjen M
Abstract excerpt
PURPOSE OF REVIEW: Artemisinin-based combination therapies (ACTs) are globally the first-line treatment for uncomplicated falciparum malaria and new compounds will not be available within the next few years. Artemisinin-resistant Plasmodium falciparum emerged over a decade ago in the Greater Mekong Subregion (GMS) and, compounded by ACT partner drug resistance, has caused significant ACT treatment failure. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
